This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Tuberculosis is a serious global health threat that infected more than 10 millio...
Many people would like to delay or even stop the aging process. Previous clinica...
After combing through 4,000 existing medications, an artificial intelligence too...
Elsewhere, cell therapy developer Turnstone Biologics announced a second round o...
CagriSema, which underperformed expectations in its first Phase 3 test, will be ...
Breakthrough research and investor enthusiasm prompted Cullinan Therapeutics to ...
As always, if you know of layoffs occurring at a biotech, please reach out to th...
That includes treating more than 200,000 patients with the irregular heartbeat k...
Glucotrack has cleared the first human clinical study of its long-term continuou...
X4 Pharmaceuticals is laying off 30% of its staff and halting preclinical R&D as...
AstraZeneca has ended development of its oral factor D inhibitor vemircopan, tri...
LinusBio aims to help physicians rule out the likelihood of autism developing in...
The “New BD,” as the company describes it, will continue on as a pure-play medte...
Kura Oncology and Kyowa Kirin claim to have scored a phase 2 win for their oral ...
Eli Lilly has invested heavily into obesity, dominating the landscape—alongside ...
Veteran scientist Hideo Makimura, M.D., Ph.D., is going fully preclinical by joi...
Eye-disease-focused Acelyrin will be absorbed into immune-mediated disease speci...
After sharing plans to shutter last summer, Asarina Pharma has managed to sell o...
Bristol Myers Squibb has continued its ruthless cost-cutting push, dropping plan...
The procedure was performed January 25 by surgeons at the Mass General Transplan...
The DNA sequencing giant said it will continue to do business in China as long a...
Researchers have used artificial intelligence to identify 25 new protein compoun...
After re-adding Blenrep to its portfolio, GSK now expects sales to reach more th...
Amar Urhekar has reset Avalere Health’s mission. Weeks after naming Urhekar as C...